IPO - PIERIS PHARMACEUTICALS, INC.

Form Type: CORRESP

Filing Date: 2025-01-15

Corporate Action: Ipo

Type: New

Accession Number: 000143774925001170

Filing Summary: Palvella Therapeutics, Inc. has submitted a request to the United States Securities and Exchange Commission to accelerate the effective date of its Registration Statement on Form S-1, originally filed on December 31, 2024, and amended on January 14, 2025. The company has requested that the statement become effective at 4:00 PM, Eastern Time, on January 16, 2025, or as soon thereafter as possible. This request indicates the company's intention to proceed with its initial public offering (IPO).

Document Link: View Document